Mainz Biomed B.v. buy Ruckelsbuckel
Start price
08.10.22
/
50%
€6.88
Target price
08.10.23
€12.00
Performance (%)
6.28%
End price
16.10.22
€7.31
Summary
This prediction ended on 16.10.22 with a price of €7.31. With a performance of 6.28%, the BUY prediction by Ruckelsbuckel for Mainz Biomed B.v. closed with a slight gain. Ruckelsbuckel has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mainz Biomed B.v. | -9.481% | -9.481% | -85.919% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% |
According to Ruckelsbuckel what are the pros and cons of Mainz Biomed B.v. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Undervalued
positive Cash Flow expected
Good rating
High Investments for future growth
Very capable Management
Good culture
Innovative
Strong uniques
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Top 10 in its market
Small cyclical dependencies
Known brand
Very Future proof/growth oriented business model
Cons
Low dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
high free float
High risks for its business